CareMax (CMAX) Tops Q4 EPS by 17c; Offers Guidance

CareMax (NASDAQ: CMAX) reported Q4 EPS of $0.10, $0.17 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $164.26 million versus the consensus estimate of $149.7 million.

GUIDANCE:

CareMax sees FY2023 revenue of $700-750 million, versus the consensus of $854 million.

For earnings history and earnings-related data on CareMax (CMAX) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c